55 related articles for article (PubMed ID: 22824147)
21. Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene.
Pelosi G; Gasparini P; Cavazza A; Rossi G; Graziano P; Barbareschi M; Perrone F; Barberis M; Takagi M; Kunimura T; Yamada T; Nakatani Y; Pastorino U; Scanagatta P; Sozzi G; Garassino M; De Braud F; Papotti M
Lung Cancer; 2012 Sep; 77(3):507-14. PubMed ID: 22705117
[TBL] [Abstract][Full Text] [Related]
22. Influence of cathepsin D expression in lung adenocarcinoma on prognosis: possible importance of its expression in tumor cells and stromal cells, and its intracellular polarization in tumor cells.
Higashiyama M; Doi O; Kodama K; Yokouchi H; Kasugai T; Ishiguro S
J Surg Oncol; 1997 May; 65(1):10-9. PubMed ID: 9179261
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.
Sarkaria IS; Zakowski MF; Pham D; Hezel M; Ebright MI; Chuai S; Venkatraman ES; Kris MG; Rusch VW; Singh B
Ann Thorac Surg; 2008 Jan; 85(1):216-23. PubMed ID: 18154814
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive histologic analysis of ALK-rearranged lung carcinomas.
Yoshida A; Tsuta K; Nakamura H; Kohno T; Takahashi F; Asamura H; Sekine I; Fukayama M; Shibata T; Furuta K; Tsuda H
Am J Surg Pathol; 2011 Aug; 35(8):1226-34. PubMed ID: 21753699
[TBL] [Abstract][Full Text] [Related]
25. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
26. Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.
Chou TY; Chiu CH; Li LH; Hsiao CY; Tzen CY; Chang KT; Chen YM; Perng RP; Tsai SF; Tsai CM
Clin Cancer Res; 2005 May; 11(10):3750-7. PubMed ID: 15897572
[TBL] [Abstract][Full Text] [Related]
27. Expression and prognostic significance of MAP4K4 in lung adenocarcinoma.
Qiu MH; Qian YM; Zhao XL; Wang SM; Feng XJ; Chen XF; Zhang SH
Pathol Res Pract; 2012 Sep; 208(9):541-8. PubMed ID: 22824148
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.
Mayer A; Fritz E; Fortelny R; Kofler K; Ludwig H
Cancer Invest; 1997; 15(2):106-10. PubMed ID: 9095205
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of cathepsin D immunostaining in colorectal adenocarcinoma.
Theodoropoulos GE; Panoussopoulos D; Lazaris AC; Golematis BC
J Surg Oncol; 1997 Aug; 65(4):242-8. PubMed ID: 9274788
[TBL] [Abstract][Full Text] [Related]
30. Cathepsin D expression in skin metastasis of breast cancer.
Inoue H; Kawada A; Takasu H; Maruyama R; Hata Y; Hiruma M; Tajima S; Ishibashi A
J Cutan Pathol; 1998 Aug; 25(7):365-9. PubMed ID: 9765021
[TBL] [Abstract][Full Text] [Related]
31. Cathepsin D expression in colorectal adenocarcinomas and adenomas.
Kanber Y; Demirbag NR; Sam AD; Aydin N
Int J Biol Markers; 2002; 17(3):165-8. PubMed ID: 12408466
[TBL] [Abstract][Full Text] [Related]
32. Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
Lösch A; Kohlberger P; Gitsch G; Kaider A; Breitenecker G; Kainz C
Br J Cancer; 1996 Jun; 73(12):1525-8. PubMed ID: 8664123
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.
Chabowski A; Sulkowska M; Sulkowski M; Famulski W; Skrzydlewska E; Kisielewski W
Folia Histochem Cytobiol; 2001; 39(2):153-4. PubMed ID: 11374801
[TBL] [Abstract][Full Text] [Related]
34. [Cytosolic cathepsin D levels in squamous carcinomas of the lung].
Ruibal A; Núñez MI; Río Mdel C; García Díez S; Rodríguez J; Alvarez de Linera JF
Med Clin (Barc); 2003 Feb; 120(3):81-4. PubMed ID: 12605727
[TBL] [Abstract][Full Text] [Related]
35. Can immunohistochemistry quantification of Cathepsin-D be useful in the differential diagnosis between vital and post-mortem wounds in humans?
Montisci M; Corradin M; Giacomelli L; Viel G; Cecchetto G; Ferrara SD
Med Sci Law; 2014 Jul; 54(3):151-7. PubMed ID: 24166688
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of the expression of collagenase IV, cathepsin D and metallothionein in squamous cell carcinomas of the skin determined by immunohistochemistry.
Goldmann T; Moorkamp A; Wiedorn KH; Suter L; Otto F
Arch Dermatol Res; 2001 Mar; 293(3):115-20. PubMed ID: 11357224
[TBL] [Abstract][Full Text] [Related]
37. Cathepsin D activity in human ovarian tissues and ovarian carcinoma.
Hradek DI; Kessel B; Husseinzadeh N; Moulton BC
J Soc Gynecol Investig; 1994; 1(2):173-7. PubMed ID: 9419767
[TBL] [Abstract][Full Text] [Related]
38. Novel biomarkers that assist in accurate discrimination of squamous cell carcinoma from adenocarcinoma of the lung.
Takamochi K; Ohmiya H; Itoh M; Mogushi K; Saito T; Hara K; Mitani K; Kogo Y; Yamanaka Y; Kawai J; Hayashizaki Y; Oh S; Suzuki K; Kawaji H
BMC Cancer; 2016 Sep; 16(1):760. PubMed ID: 27681076
[TBL] [Abstract][Full Text] [Related]
39. Cathepsin D cytosol content in colorectal cancer.
Villar C; Rodríguez JC; Raigoso PF; García-Muñiz JL; Martínez E; Vizoso F
Int J Biol Markers; 1999; 14(3):192-4. PubMed ID: 10569144
[No Abstract] [Full Text] [Related]
40. Expression of cathepsin D in colorectal adenocarcinomas: correlation with clinicopathologic features.
Yilmaz F; Uzunlar AK; Kilinc N; Yilmaz HG
Ann Saudi Med; 2003; 23(3-4):208-11. PubMed ID: 16985323
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
